<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D9EFD5B9-6F3D-4279-8740-A4351E58710E"><gtr:id>D9EFD5B9-6F3D-4279-8740-A4351E58710E</gtr:id><gtr:name>Carl Zeiss AG</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1ET</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D9EFD5B9-6F3D-4279-8740-A4351E58710E"><gtr:id>D9EFD5B9-6F3D-4279-8740-A4351E58710E</gtr:id><gtr:name>Carl Zeiss AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1FF61108-E342-4618-805C-FFDCCB826C2F"><gtr:id>1FF61108-E342-4618-805C-FFDCCB826C2F</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Geoffrey</gtr:otherNames><gtr:surname>Spiller</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C047998C-37DB-4DCE-98E1-A4BA02F0D930"><gtr:id>C047998C-37DB-4DCE-98E1-A4BA02F0D930</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>White</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FE013600%2F1"><gtr:id>1E926A55-6211-44DE-B01C-41DD7C38E6D2</gtr:id><gtr:title>Dynamic modulators: Novel effectors of NF-kappaB signalling</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E013600/1</gtr:grantReference><gtr:abstractText>The NFkappaB pathway is widely recognised as crucial to a variety of important cellular processes including both proliferation and apopotosis. It is correspondingly implicated in a variety of pathologies such as cancer and inflammatory disease. In recent work (e.g. Nelson, D. E., Ihekwaba, A. E. C., Elliott, M., Gibney, C. A., Foreman, B. E., Nelson, G., See, V., Horton, C. A., Spiller, D. G., Edwards, S. W., McDowell, H. P., Unitt, J. F., Sullivan, E., Grimley, R., Benson, N., Broomhead, D. S., Kell, D. B. &amp;amp; White, M. R. H. (2004). Oscillations in NF-kappaB signalling control the dynamics of target gene expression. Science 306, 704-708), we have shown that signalling in the NFkappaB likely operates not by modulations in the amplitude of NFkappaB per se but in its frequency or dynamics. We therefore need tools that can modulate these differentially, and chemical genomics provides an exciting prospect for acquiring them. An important set of such tools is represented by small (drug-like) molecules, and a useful strategy is to screen libraries of them for molecules with the desired activities. As we obtain 'hits' that are active in the way we require we shall study their structures and properties in a computer so as to screen 'virtually' much larger libraries of available molecules for substances that have appropriate chemical similarities, and then screen these too. This will lead to molecules with higher potency and thus higher specificity. These will be improved still further by making variants synthetically and again testing them. The most potent molecules (those with the highest affinity) will be immobilised on a column and used to fish out the target(s) to which they bind, thus allowing the identification of the target(s). Attractive features of this strategy are that (i) we do not need to know the 'target' that is necessary to affect the dynamics in the first place, (ii) targets may come from any pathway, (iii) we may find targets in quite 'distant' areas of the cellular network that were not even known or considered to interact functionally with the NFkappaB pathway, (iv) we thereby acquire a series of reagents that can modulate the dynamics of biological signalling pathways.</gtr:abstractText><gtr:technicalSummary>Most cellular signalling systems are arranged in a 'bowtie' configuration, in which multiple extracellular stimuli can cause multiple downstream responses, but they do so by using only a comparatively small number of signalling intermediates. It is not obvious a priori how crosstalk can therefore be avoided. Using single-cell time lapse video imaging together with numerical modelling, we have shown that individual steps in the NF-kappaB signalling pathway can differentially affect both the amplitude and the frequency of the oscillatory behaviour of the nuclear NFkappaB concentration. This has led us to suggest that it is the DYNAMICS, rather than the amplitude, of such signals that control downstream events (a phenomenon that in principle can deal with the crosstalk problem entirely). What we need to help develop this new idea, therefore, are experimental methods that can conveniently manipulate the two aspects of these dynamics independently. Chemical genomics provides a novel approach by which we can acquire reagents with the necessary specificities and activities. These candidate reagents will be screened in our single-cell assays using cellular arrays, and their important properties assessed in silico by the use of QSAR methods, which will allow us to 'cherry pick' from other libraries and thus improve their likely potency. The most potent molecules will be improved further by the methods of synthetic and medicinal chemistry. By using whole cell assays we shall automatically be able to interrogate all pathways that are functionally linked to the NFkappaB pathway, and by immobilising the most potent molecules we shall be able to purify the proteins with which they interact. The deliverable will be a series of reagents that can differentially affect the amplitudes and dynamics of components of the NFkappaB signalling pathway.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>456292</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Carl Zeiss AG</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Carl Zeiss</gtr:description><gtr:id>7E4BC1B3-1B27-4E9E-82DF-B4DC4B7E88DA</gtr:id><gtr:impact>Annual training courses
MICA collaborative MRC grant
MICA collaboration on new single cell centre

The relationship with Zeiss has been two way. We have been given the opportunity to be early adopters f new technology and to feedback idease for improvement. We receive very favourable deals on microscope purchases and maintenance contracts. Specific areas of successful collaboration lie in improvements to higher throughput live cell imaging using the confocal microscopes; optimisation of truly dark microscopes for quantitative luminescence imaging and the development of FCS.

Multiple workshops organised (2-3 per yeat)</gtr:impact><gtr:outcomeId>i8rjFqtYhvF-1</gtr:outcomeId><gtr:partnerContribution>Zeiss have made a cash contribution to training courses (received) of &amp;pound;16,250. Zeiss estimate of total value of in-kind staff time for collaboration, training courses and other meetings (including visits of teams from Germany) ?25,000. In addition, Zeiss have also committed over &amp;pound;30,000 in cash and ~&amp;pound;80000 in in kind staff for future training meetings and collaborative visits. 
Zeiss helped to design the new Systems Microscopy Centre in Manchester and made a 45% discount (value ?350k) for the purchase of equipment in 2011. Zeiss are a formal MICA partner on both Liverpool and Manchester awards from the MRC/BBSRC New Microscopy Initiative. In the award to Manchester they have made a contribution of &amp;pound;614,314 in staff time, development costs and equipment contribution. This involves FCS (developed during this project), luminescence fluorescence imaging, light sheet microscopy and SOFI super-resolution imaging. More recently Zeiss have made a further contribution to our new clinical single cell centre. This includes over &amp;pound;400k in equipment discounts and &amp;pound;25k in cash contribution to training and symposia.
Over the years the Zeiss contributions have included them helping us with public understanding of science exhibitions where they loaned equipment, provided support for professional poster preparation and used their delivery services to transport our exhibit materials and equipment to the exhibition venues. This included an exhibition in Buckingham Palace in 2006.
Zeiss have sponsored 2-3 meetings per year in Manchester. In 2016 this included a session on light sheet imaging and a session on new confocal imaging technologies. In 2017 they have sponsored an image analysis daya and will sponsor a single cell biology workshop.</gtr:partnerContribution><gtr:piContribution>We have advised Zeiss on trends in bioimaging since 1996. We have provided new data and tested prototype equipment. We have spoken at Zeiss organised meetings. We have given them an opportunity to display Zeiss equipment at our training courses. We have organised symposia that have been supported by Zeiss. We have held expert discussion meetings to review microscopy trends that have involved senior Zeiss staff</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit (Liverpool Life Sciences, University Technical College)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C1FE5D7C-0F89-48D8-B6E8-D8141A24F525</gtr:id><gtr:impact>Liverpool Life Sciences UTC is the first school in the UK specialising in Science and Health Care for 14 to 19 year olds. Talk at Liverpool Life Sciences UTC conference on &amp;quot;How Organisms Age&amp;quot;</gtr:impact><gtr:outcomeId>58ca77881fc957.64857107</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit, Altrincham Girls School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>765A6122-9539-472B-9002-0BD505991A82</gtr:id><gtr:impact>Dean Jackson - Advice and practice interviews for students</gtr:impact><gtr:outcomeId>58ca72f9d67e53.28263101</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4160524</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Lola</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef> BB/K003097/1</gtr:fundingRef><gtr:id>4987CC52-67A2-43C7-9C60-DD7EC84E94AE</gtr:id><gtr:outcomeId>Xdp7TFUFPEq</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>31026</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Japanese Partnering Award</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/G530276/2</gtr:fundingRef><gtr:id>5D1390F8-1DB0-44C6-8D2E-2386940F90D2</gtr:id><gtr:outcomeId>pcKypEwga1c0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5072010</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dynamics and function of the NF-?B signalling system</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/F005938/2</gtr:fundingRef><gtr:id>1CC22498-EF6F-4540-A031-FD25836116A9</gtr:id><gtr:outcomeId>53db7887747779.89331202</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Ongoing interest in the work from CRT, GSK and AZ.</gtr:description><gtr:id>847FC4D9-08BE-4928-9D7E-3D4CE84F9E7D</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56ddfd74a7cd75.78554042</gtr:outcomeId><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Chemiinformatic analysis and classification of a broad set of NF-kB modulators

Identification of the drugs aspirin and diclofenac as modulators of NF-kB oscillation period.</gtr:description><gtr:exploitationPathways>New screens planned with pharmaceutical companies to benefit from this early screen.

The results with aspirin and diclofenac are very interesting and may suggest future utility.</gtr:exploitationPathways><gtr:id>20152F7E-45E1-4787-B402-EAB1AF0167A1</gtr:id><gtr:outcomeId>56ddfd2c2398c3.08356390</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Panel: Enabling Theme 2, the Exploiting New Ways of Working Strategy Panel (ENWW)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>18EC14AD-46F7-4EF8-80F4-3D98F2C30D96</gtr:id><gtr:outcomeId>riBfcac3je2</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of MRC Doctoral Training Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9DB52A73-CA30-4D5B-B5DC-4B32E3CA3956</gtr:id><gtr:outcomeId>E5DDLDFEd7s</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Appointed to Pool of Experts for BBSRC Panels, 2012-2013.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F6F97259-8450-4060-824F-3355BE531F78</gtr:id><gtr:outcomeId>rgc51j4k6oZ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Trust/Wolfson Capital Awards in Biomedical Sciences Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AC7606EA-E4B7-4FF5-82F6-9D4AC984EFF4</gtr:id><gtr:outcomeId>RPPFikr7KT7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC/EPSRC TDRI Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D5D09CF2-CD16-4689-AB85-3CB330D7844E</gtr:id><gtr:outcomeId>Xms5gDPEt91</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of MRC Population and System Medicine Board, 1 April 2012 - 1 April 2016</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4F4D3395-B17C-4422-8E41-7251DA8CC8E3</gtr:id><gtr:outcomeId>GPvJF3EsqEr</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Bioscience for Industry Committee (single meeting for presentation)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4D122E18-2F5C-4AE1-AB99-84D30014EA6C</gtr:id><gtr:outcomeId>H3Sci3mDtx1</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>External Reviewer for FRISYS-ZBSA (Zentrum fur biosystemanalyse), Freiberg, Germany, 26th May 2011.</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>11BC95D0-2015-4ACE-AE9A-8DF579B2457A</gtr:id><gtr:outcomeId>CMtJqz47g26</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Tools and Resources Development Fund Panel, Feb 2012.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CBC01DA9-51AB-4858-8B5A-5B99D42685AF</gtr:id><gtr:outcomeId>tLZAjo7VmqU</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Systems Immunology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FBCD6D76-4ED7-4992-A526-62921218E0B7</gtr:id><gtr:outcomeId>ikEgUKbYUuJ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Site visit to Oxford Centre for Systems Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ABD77A81-BE21-47A5-AA62-495C40FA8257</gtr:id><gtr:outcomeId>dLQuSozmxAs</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Microbiome</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DEAA89CC-B680-40A6-AC5B-FC2E631AFCE2</gtr:id><gtr:outcomeId>UHVaTGTTYuh</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Invited to attend Research Sponsors' Consultation Meeting (BBSRC &amp;amp;MRC) on Imaging for the biological and biomedical sciences, 14 May 2012.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D5318DBA-18F5-4C8C-99BB-771D0E057553</gtr:id><gtr:outcomeId>Vi7N2FEHYfR</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of BBSRC Interdisciplinary Systems Biology Strategy Committee</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>FEA9066F-5587-4403-A764-4AB4E095BB56</gtr:id><gtr:outcomeId>76DBBCB53BF</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC/BBSRC New Microscopy Initiative</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>45FD4781-9DC3-418D-989E-6394ACE83EB3</gtr:id><gtr:outcomeId>E7iSQ5JAkkZ</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Research Equipment Initiative (REI) Review Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C16C3044-BED2-4767-BA99-8CAEB1E8EFCB</gtr:id><gtr:outcomeId>LaFbgzKTd7U</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Strategic Tools and Resources Development Fund (sTRDF) Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3A34EB3E-5008-457E-B226-651B1780E943</gtr:id><gtr:outcomeId>Qzw98FM5zsM</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>German Virtual Liver Scientific Advisory Board (42m euros programme )</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>97A6B295-16A9-4475-AAE7-6985165C4F56</gtr:id><gtr:outcomeId>SQ6EWWziHpg</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.virtual-liver.de/wordpress/en/media/handling-biological-complexity-using-systems-approaches-4/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Site visit to Imperial Centre for Systems Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5EDE0B2A-35E1-4368-9822-813D424C596B</gtr:id><gtr:outcomeId>JbZCKGpR49Z</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A129C517-8D40-454C-B319-DA1754109EA4</gtr:id><gtr:title>Measurement of single-cell dynamics.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16dd1bc3a81880422ff91e01ec156a56"><gtr:id>16dd1bc3a81880422ff91e01ec156a56</gtr:id><gtr:otherNames>Spiller DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>BFfHFELQHzo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DE1314D-4768-418F-BD84-95E9D47F9B63</gtr:id><gtr:title>NF kappa B inhibitors promote cell death in both S and N type neuroblastoma cell lines</gtr:title><gtr:parentPublicationTitle>PEDIATRIC BLOOD &amp; CANCER</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a514aadd6b1d05061f2e92d553b7483b"><gtr:id>a514aadd6b1d05061f2e92d553b7483b</gtr:id><gtr:otherNames>Mullasserv Dhanva</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>56dd437de976d0.54178423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFB9BF98-929D-463C-A689-D9C4E9072567</gtr:id><gtr:title>Single live-cell imaging for systems biology.</gtr:title><gtr:parentPublicationTitle>Essays in biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ac63894ccb781329b1b5aab30dd2fd7"><gtr:id>9ac63894ccb781329b1b5aab30dd2fd7</gtr:id><gtr:otherNames>Mullassery D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0071-1365</gtr:issn><gtr:outcomeId>7D69D0435ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25096959-D93A-456C-9F22-0DED0166F088</gtr:id><gtr:title>Predicting the points of interaction of small molecules in the NF-?B pathway.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8766afa6a4f20ca9202f47f25c579167"><gtr:id>8766afa6a4f20ca9202f47f25c579167</gtr:id><gtr:otherNames>Patel Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>doi_14397__0509_5_32</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E013600/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>